Skip to content

What is Alzheimer's disease?

Alzheimer’s disease is the most common cause of dementia, thought to account for over 50% of cases. Like most other types of dementia, Alzheimer’s disease is progressive, with symptoms worsening over time.

The brain changes typically found in Alzheimer's disease were first described by the German psychiatrist Alois Alzheimer in 1906.  

Alzheimer’s disease used to be most frequently diagnosed when people already had dementia and were experiencing quite noticeable problems with memory loss, thinking ability and daily activities.

Nowadays, Alzheimer’s disease is considered a continuum ranging from a pre-clinical (at-risk for dementia) state, to a form of mild cognitive impairment with only minor problems with daily activities and on to mild, moderate and severe dementia with increasing loss of cognitive and everyday function.

The disease progression

Alzheimer’s disease begins many years before symptoms become apparent and develops gradually over time.

As people progress along the Alzheimer’s disease continuum, cognitive and functional impairments gradually become more severe, with an eventual loss of independence and hence, a need for support from other people. However, it is important to understand that progression along the Alzheimer’s disease continuum varies considerably from person to person and that each person’s experience of Alzheimer’s disease will be unique to them.

Moreover, in keeping with the United Nations Convention on the Rights of People with Disabilities, dementia is also considered a disability. Article 1 states:

"(p)ersons with disabilities include those who have long-term physical, mental, intellectual or sensory impairments which in interaction with various barriers may hinder their full and effective participation in society on an equal basis with others"

For this reason, it is important to consider the physiological/biomedical aspects of Alzheimer’s disease but also the interaction between people with cognitive impairment, other people, situations and societal structures as this, in addition, impacts on the wellbeing, opportunities and overall experience of having dementia.

Latest news

🩺 Closing the Gap: Strengthening Europe’s Path to Timelier, Fairer Dementia Diagnosis

News

🩺 Closing the Gap: Strengthening Europe’s Path to Timelier, Fairer Dementia Diagnosis

Have you ever wondered what happens when someone walks into their GP surgery worried about their memory - and whether that first step toward a dementia diagnosis looks the same across Europe?

Read more
PREDICTOM Level 2 Clinical Study has started

News

PREDICTOM Level 2 Clinical Study has started

The PREDICTOM is pleased to announce the launch of Level 2 of its international clinical study—an important next step made possible entirely through the generosity, time, and commitment of participants across Europe. The participants' contributions continue to drive forward our shared goal: improving the early detection of Alzheimer’s disease through accessible, reliable, and science-driven tools.

Read more
📢 PREDICTOM Study Progress

News

📢 PREDICTOM Study Progress

Every contribution tells a story—and together, we’re shaping the future of brain health.

Read more